What question did this study set out to answer?

This research aims to explore the effects of MMP9 inhibition on signaling networks and identify biomarkers in non-small cell lung cancer.

Systems Biology and Experimental Validation Enable Discovery of MMP9-Centered Networks, Anticancer Activity, and Pharmacodynamic Signature in Non-Small Cell Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial identifies MMP9 pharmacodynamic biomarkers in non-small cell lung cancer, suggesting targeted strategies for treatment.

This research aims to explore the effects of MMP9 inhibition on signaling networks and identify biomarkers in non-small cell lung cancer.
Combined systems biology with experimental validation to analyze MMP9 signaling in NSCLC.
Evaluated compounds' effects in purified enzyme assays and A549 cancer cells.
Conducted quantitative PCR for gene expression analysis.
Compounds M34 and M33 inhibited MMP9 activity by 65.01% and 61.32% at 50 μM, respectively.
Seven compounds showed antiproliferative effects (IC50 = 40–115 μM) and reduced MMP9 protein expression.
Establishment of an eight-gene pharmacodynamic biomarker signature for MMP9-targeted strategies.

Rashid et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark